MRD / Regn No. : SG004604 Date : 23/06/2026
Patient Name : Rina Singh Age & Gender : 50 Yrs. / Female
Contact No. : 6290000381 UHID :
Ht / Wt / BMI : 158 / 60 / 24.03 BP S / BP D : 139 / 81
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (23/Jun/2022) | DYSLIPIDEMIA (23/Jun/2026) |
Subjective : NO MEDICINES FOR 6 MONTHS
Salient Investigations : TGL TRIGLYCERIDE: 104 mg/dL | CREATININE: 0.7 | EGFR EGLOMERULAR FILTRATION RATE: 94.79 mL/min/1.73m2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 10.8 % | LDL LOW DENSITY LIPOPROTEIN: 91 mg/dL | MICROALBUMIN CREATININE RATIO: 10.4 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
ZEXRIDA L 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 TABLET ROSUVASTATIN 10 MG
STATEZE R 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 23/Dec/2026
Tests Suggested For Next Visit : CHECK FASTING & PP SUGARS AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: